• 2018-07
  • 2019-04
  • 2019-05
  • 2019-06
  • 2019-07
  • 2019-08
  • 2019-09
  • 2019-10
  • 2019-11
  • 2019-12
  • 2020-01
  • 2020-02
  • 2020-03
  • 2020-04
  • 2020-05
  • 2020-06
  • 2020-07
  • 2020-08
  • 2020-09
  • br Results and discussion To check the hypothesis


    Results and discussion To check the Index Kit 2 that the charge of α-synuclein can be altered due to the glycation, we measured zeta potential of native α-synuclein and α-synuclein glycated by two different glycating agents, methylglyoxal (MG) and glyceraldehyde-3-phosphate (GA-3-P). The value for native α-synuclein was −15.9 ± 5.1 mV indicating negative net charge at pH 7.0, which agrees well with the data on isoelectric point of α-synuclein (4.7). The value for α-synuclein glycated by MG was almost the same whereas glycation by GA-3-P resulted in significant increase of zeta potential in absolute value up to −21.5 ± 2.7 mV (Fig. 1). In other words, glycation by GA-3-P caused increase of the α-synuclein net charge to more negative values suggesting modification of positively charged groups of lysine to neutral or negatively charged groups. According to measuring free amino groups, 5 and 8 lysine residues were modified MG and GA-3-P respectively (data not shown). Then we performed molecular modeling of the interaction between glycated α-synuclein and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) using molecular dynamics simulations. Unfortunately, modeling of the modifications of unfolded protein consisting in cross-linking such as formation of methylglyoxal lysine dimers is too complicated because of many different variations of cross-linked pairs, both inter- and intramolecular. Furthermore, according to the data of SDS PAGE, α-synuclein preparations glycated by MG or GA-3-P yielded 18-kDa band corresponding to the monomer of α-synuclein indicating the absence of inter-molecular cross-linking [38]. Therefore we selected non-cross-linking modification, i.e. formation of N-ε-carboxymethyl lysine (CML, see Fig. 2C for the structure), which is one of the most common advanced glycation product [[39], [40], [41]]. Noteworthy, this modification is associated with change of the protein charge to more negative value, which occurs in the case of α-synuclein glycation by GA-3-P according to zeta potential measurement (Fig. 1). Two different forms of glycated α-synuclein were analyzed: with two modified lysine residues (96 and 102), which undergo SUMOylation in vivo [42], and with nine modified lysine residues (6, 10, 12, 21, 23, 32, 34, 43, and 96), which undergo ubiquitination in vivo [43,44] (denoted as g-α-synuclein and g2-α-synuclein, respectively). The choice of modification was based on the idea that they cannot be utilized by protein quality control system in contrast to α-synuclein molecules glycated at other sites, and therefore can exhibit a high impact on the cell. Noteworthy, these two models allow estimating influence of different levels of glycation: low (two modified residues) and high (nine modified residues) glycation level. For both forms (and the native α-synuclein as well) 10 independent simulations with different initial position of α-synuclein were performed. The stoichiometry 1:1 was selected for simulations because of two reasons: a small stoichiometry value was expected since the size of the complex of GAPDH and unmodified α-synuclein is similar to the size of free GAPDH [28], and introducing additional protein molecules would result in significant increase of the box size and, consequently, computational cost since both molecules are large.